Steven Rosenberg

Um, I, I believe there's a reason this happened, is that we have three FDA people, okay? And they know that this works.

Don't forget that Steven Rosenberg heads the National Cancer Institute.

He's the founder of Til from 1986, so I'm telling you that he's got something to say about this.

So what's happening, in my opinion, is...

And if it wasn't for immune checkpoint inhibitors, it probably would be used routinely in our practice.

I think it was developed in the U.S. by Dr. Steve Rosenberg, and he had really promising results.

There was a lot of argument as whether you had patient selection as the reason why patients did well.

So there was some of those concerns.

But I think before I go there, there's a, there's a black box that exists that is the world you occupy that I really think it's unknown by the public, but I think it would be very insightful if people understood it, and it is the process by which a drug is discovered.

The first person who I ever read articulating this was Steve Rosenberg.

Wrote one of my favorite books about science called "The Transformed Cell".

This book is, uh, over 30 years old.